ClinConnect ClinConnect Logo
Search / Trial NCT06944795

SWIR Otoscopy Study

Launched by STANFORD UNIVERSITY · Apr 18, 2025

Trial Information

Current as of July 22, 2025

Not yet recruiting

Keywords

Middle Ear Infections Ear Infections Pediatric Ear Infections Otitis Media Chronic Otitis Media Chronic Otitis Media With Effusion

ClinConnect Summary

The SWIR Otoscopy Study is a clinical trial designed to see if a new type of ear examination tool, called a short wave infrared (SWIR) otoscope, is better than a traditional white light otoscope for diagnosing middle ear infections, also known as otitis media. This study will involve children aged 1 to 17 who are visiting the Ear, Nose, and Throat Clinic at Lucile Packard Children's Hospital to have a procedure called tympanostomy tube placement. During the procedure, both types of otoscopes will be used to check for fluid in the middle ear, and the results will help determine if the new tool is more effective.

To participate in this study, children must be between the ages of 1 and 17 and scheduled for the tympanostomy tube placement at the clinic. Their parents or guardians will need to understand and agree to the study by signing a consent form. The study is not yet recruiting, so participants will be informed about the process and what to expect when the study begins. Overall, this research aims to improve how doctors diagnose ear infections, which can help children get the right treatment more quickly.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Ages 1-17
  • Being seen in the Ear, Nose, and Throat Clinic at Lucile Packard Childrens Hospital
  • Undergoing tympanostomy tube placement as part of standard of care
  • Parents and/or patient has the ability to understand and the willingness to sign a written informed consent form or assent form.
  • Exclusion Criteria:
  • Patients under 1 year of age or 18 and older
  • Participants not meeting the inclusion criteria

About Stanford University

Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.

Locations

Palo Alto, California, United States

Washington Dc, District Of Columbia, United States

Patients applied

0 patients applied

Trial Officials

Tulio Valdez, MD, MSc

Principal Investigator

Stanford University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported